GL1X · GenesisL1 explorer

MolNFT v1 · #124794 · protein

Structure of human PARP1 catalytic domain bound to a quinazoline-2, 4(1H,3H)-dione inhibitor

5KPP · Poly [ADP-ribose] polymerase 1: “Structure of human PARP1 catalytic domain bound to a quinazoline-2, 4(1H,3H)-dione inhibitor”. X-ray diffraction, 1 ligand (6WZ), 8 pockets (best druggability 0.80). MolNFT v1 #124794 on GenesisL1…

PDB
5KPP
Type
protein
Length
698 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30
UniProt
P09874
Ligands
6WZ
Pockets
8 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein34940% helix, 25% strandP09874

Ligands and binding sites

  • 6WZ · 1-[[4-fluoranyl-3-[(3R)-3-methyl-4-[2,2,2-tris(fluoranyl)ethyl]piperazin-1-yl]carbonyl-phenyl]methyl]quinazoline-2,4-dione · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13910.800.89376WZ
23950.800.89366WZ
32590.670.8437empty
4910.540.8516empty
5510.470.8618empty

Interfaces

1 interface between chains.

  • A–B · 865 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 5KPP · Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.